Since its beginnings in the mid-1990s, Newport Laboratories has been recognized as a leader in swine diagnostics and vaccine production. Today, we are the nation’s leading manufacturer of autogenous biologics, and the industry leader in Swine Influenza Virus diagnostics and vaccine development.

Newport remains on the leading edge of research and development searching for answers to the swine industry’s most pressing health issues.

Focus antigens include:

• APP
• Clostridium difficile
• Clostridium perfringens, A & C
• E. coli
• Erysipelas
• Haemophilus parasuis
• Mycoplasma hyopneumoniae
• Mycoplasma hyorhinis
• Mycoplasma hyosynoviae
• PRRSV
• Rotavirus
• Streptococcus suis
• Swine Influenza Virus

We are able to build combination products containing any or all of these antigens to best meet the needs of specific herds/regions.